Globe Life (NYSE:GL) Releases FY 2025 Earnings Guidance

Globe Life (NYSE:GL) updated its FY 2025 earnings guidance on Wednesday. The company provided EPS guidance of 13.450-14.050 for the period, compared to the consensus EPS estimate of 13.580. The company issued revenue guidance of -.

Analyst Ratings Changes

Several brokerages have recently weighed in on GL. BMO Capital Markets initiated coverage on Globe Life in a report on Thursday, January 23rd. They set a “market perform” rating and a $114.00 price objective on the stock. Truist Financial raised their price objective on shares of Globe Life from $90.00 to $105.00 and gave the stock a “hold” rating in a report on Friday, October 25th. TD Cowen began coverage on shares of Globe Life in a research note on Wednesday, October 9th. They issued a “buy” rating and a $150.00 target price on the stock. Evercore ISI raised Globe Life from an “in-line” rating to an “outperform” rating and lifted their price objective for the company from $132.00 to $143.00 in a report on Wednesday, January 8th. Finally, Keefe, Bruyette & Woods increased their price target on Globe Life from $135.00 to $137.00 and gave the stock an “outperform” rating in a research report on Friday, January 10th. Five investment analysts have rated the stock with a hold rating, six have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $132.18.

Globe Life Price Performance

Shares of GL traded up $0.52 during midday trading on Wednesday, hitting $122.93. The company’s stock had a trading volume of 587,098 shares, compared to its average volume of 551,996. The company’s fifty day simple moving average is $112.78 and its two-hundred day simple moving average is $106.53. Globe Life has a one year low of $38.95 and a one year high of $132.00. The company has a quick ratio of 0.05, a current ratio of 0.05 and a debt-to-equity ratio of 0.50. The stock has a market capitalization of $10.32 billion, a price-to-earnings ratio of 10.40 and a beta of 0.81.

Globe Life (NYSE:GL) last announced its earnings results on Wednesday, February 5th. The company reported $3.14 EPS for the quarter, beating the consensus estimate of $3.12 by $0.02. Globe Life had a return on equity of 22.91% and a net margin of 19.04%. As a group, equities analysts expect that Globe Life will post 12.32 earnings per share for the current fiscal year.

Globe Life Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, January 31st. Shareholders of record on Monday, January 6th were paid a $0.24 dividend. The ex-dividend date of this dividend was Monday, January 6th. This represents a $0.96 annualized dividend and a dividend yield of 0.78%. Globe Life’s payout ratio is presently 8.12%.

Insider Activity at Globe Life

In other news, Director Mark A. Blinn sold 3,000 shares of the stock in a transaction dated Monday, January 6th. The shares were sold at an average price of $113.23, for a total transaction of $339,690.00. Following the completion of the sale, the director now directly owns 5,122 shares in the company, valued at approximately $579,964.06. This represents a 36.94 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Frank M. Svoboda sold 14,340 shares of the firm’s stock in a transaction on Tuesday, December 3rd. The stock was sold at an average price of $108.80, for a total value of $1,560,192.00. Following the completion of the sale, the chief executive officer now directly owns 16,396 shares of the company’s stock, valued at $1,783,884.80. The trade was a 46.66 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 39,788 shares of company stock worth $4,429,779. 1.51% of the stock is owned by company insiders.

About Globe Life

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.